We have tested the hypotheses that glycopyrrolate, administered immediately before induction of subarachnoid anaesthesia for elective Caesarean section, reduces the incidence and severity of nausea, with no adverse effects on neonatal Apgar scores, in a double-blind, randomized, controlled study. Fifty women received either glycopyrrolate 200 micrograms or saline (placebo) i.v. during fluid preload, before induction of spinal anaesthesia with 2.5 ml of 0.5% isobaric bupivacaine. Patients were questioned directly regarding nausea at 3-min intervals throughout operation and asked to report symptoms as they arose. The severity of nausea was assessed using a verbal scoring system and was treated with increments of i.v. ephedrine and fluids. Patients in the group pretreated with glycopyrrolate reported a reduction in the frequency (P = 0.02) and severity (P = 0.03) of nausea. Glycopyrrolate also reduced the severity of hypotension, as evidenced by reduced ephedrine requirements (P = 0.02). There were no differences in neonatal Apgar scores between groups.
Metoclopramide was given i.m. or i.v. to patients who had been given an opioid premedication, and the effects on gastric emptying assessed. Forty patients were allocated randomly to one of four treatment groups: group 1, oral diazepam 10 mg; group 2, i.m. morphine 10 mg; group 3, i.m. morphine 10 mg and i.v. metoclopramide 10 mg; group 4, i.m. morphine 10 mg and i.m. metoclopramide 10 mg. Gastric emptying was estimated from the absorption of oral paracetamol. I.v. metoclopramide antagonized the reduction in paracetamol absorption caused by morphine, whereas i.m. metoclopramide did not. This finding may be of importance in anaesthesia for emergencies.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.